Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Hirsch

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Histopathology|November 1, 1994
Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodiesB G Skov, A F Lauritzen, F R Hirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinomaB G Skov, J B Sørensen, F R Hirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Chemoprevention of lung cancer--from biology to clinical realityR C Winterhalder, F R Hirsch, G K Kotantoulas, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Expression of 'small cell carcinoma antigens' in primary small cell lung cancer and metastases: an immunohistochemical studyB G Skov, F R Hirsch, F G Hay, et al.
British Journal of Cancer|February 23, 1999
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progressionU N Lassen, K Osterlind, F R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
Are pathologists biased by clinical information?: A blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinomaB G Skov, O Braendstrup, F R Hirsch, et al.
Cancer Research|December 1, 1983
Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lungK Osterlind, S Sörenson, H H Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patientsF R Hirsch, H H Hansen, M Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
The impact of abdominal computerized tomography on the pretreatment staging and prognosis of small cell lung cancerF R Hirsch, K Osterlind, L I Jensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimensK Osterlind, M Hansen, F R Hirsch, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Histopathology|November 1, 1994
Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodiesB G Skov, A F Lauritzen, F R Hirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinomaB G Skov, J B Sørensen, F R Hirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Chemoprevention of lung cancer--from biology to clinical realityR C Winterhalder, F R Hirsch, G K Kotantoulas, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Expression of 'small cell carcinoma antigens' in primary small cell lung cancer and metastases: an immunohistochemical studyB G Skov, F R Hirsch, F G Hay, et al.
British Journal of Cancer|February 23, 1999
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progressionU N Lassen, K Osterlind, F R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
Are pathologists biased by clinical information?: A blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinomaB G Skov, O Braendstrup, F R Hirsch, et al.
Cancer Research|December 1, 1983
Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lungK Osterlind, S Sörenson, H H Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patientsF R Hirsch, H H Hansen, M Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
The impact of abdominal computerized tomography on the pretreatment staging and prognosis of small cell lung cancerF R Hirsch, K Osterlind, L I Jensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimensK Osterlind, M Hansen, F R Hirsch, et al.
Pageof 8